Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
US Army
Chubb
Deloitte
Express Scripts
US Department of Justice
Covington
Johnson and Johnson

Generated: April 25, 2018

DrugPatentWatch Database Preview

LODOSYN Drug Profile

« Back to Dashboard

When do Lodosyn patents expire, and when can generic versions of Lodosyn launch?

Lodosyn is a drug marketed by Aton and is included in one NDA.

The generic ingredient in LODOSYN is carbidopa. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the carbidopa profile page.
Drug patent expirations by year for LODOSYN
Medical Subject Heading (MeSH) Categories for LODOSYN
Synonyms for LODOSYN
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid
(+)-2-(3,4-Dihydroxybenzyl)-2-hydrazinopropionic acid monohydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropionic acid monohydrate
(2S)-3-(3,4-DIHYDROXYPHENYL)-2-HYDRAZINYL-2-METHYL-PROPANOIC ACID
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid monohydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid-water (1/1)
(alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
(alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate
(S)-?-Hydrazino-?-methyl-?-(3,4-dihydroxyphenyl)propionic acid
(S)-(-)-carbidopa
(S)-(-)-carbidopa hydrate
(S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid
(S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropionic Acid
(S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
(S)-alpha-Hydrazino-3,4-dihydroxy-alpha-methyl-benzenepropanoic acid monohydrate
(S)-carbidopa
(S)-carbidopahydrate
27925-91-3
28860-95-9
31823-41-3
60C959
AB00441332_07
AB00441332_08
AB00441332-05
AB00441332-06
AB2000353
AC-1676
AC1L1RFR
AC1Q5QGW
AK326162
AKOS015969657
alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid
alpha-Methyldopahydrazine
AM021666
AN-14724
AOB5343
API0000921
AS-16862
BB_SC-5095
BDBM50418773
Benzenepropanoic acid, a-hydrazino-3,4-dihydroxy-a-methyl-
Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, (S)-
BG0127
C-126
C-DOPA
carbidopa
Carbidopa (anhydrous)
Carbidopa [INN]
Carbidopa [USAN:INN:BAN]
Carbidopa anhydrous
Carbidopa, (S)-Isomer
Carbidopa, Entacapone, & Levodopa
Carbidopum
Carbidopum [INN-Latin]
carbidopum monohydricum
CAS-28860-95-9
CCG-204476
CCRIS 5093
CHEBI:39585
CHEMBL1201236
CS-2351
D0P7JZ
DB00190
DR000462
DSSTox_CID_2735
DSSTox_GSID_22735
DSSTox_RID_76707
DTXSID4022735
EINECS 249-271-9
EU-0100382
FT-0602918
GP7031
GTPL5159
Hadrazino-alpha-methyldopa
HMS2089B12
HMS3266A20
HMS3655G20
HY-B0311
HYDROCINNAMIC ACID, alpha-HYDRAZINO-3,4-DIHYDROXY-alpha-METHYL-, L-
KINSON, 3-(3,4-DIHYDROXY-PHENYL)-2-HYDRAZINO-2-METHYL-PROPIONIC ACID
KR87B45RGH
KS-00000Y5G
L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid
L-alpha-(3,4-dihydroxybenzyl)-alpha-hydrazinopropionic acid monohydrate
L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid
L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid
L-alpha-Methyldopahydrazine
Lodosin
Lodosyn (TN)
Lodosyn, Carbidopa
Lopac0_000382
LS-77199
M-1664
Methyldopahydrazine
MFCD00069231
MK 486
MK-485
MK-486
MLS-0072919
MLS-0072919.P013
MLS000069628
MLS002207014
MolPort-003-940-629
MolPort-046-033-689
N-Aminomethyldopa
NCGC00024596-01
NCGC00024596-03
NCGC00024596-05
NCGC00024596-06
NCGC00024596-07
NCGC00024596-08
NSC-751137
NSC751137
OR257241
RDL0000336
S-(-)-alpha-Hydrazino-3,4-dihydroxy-2-methylbenzenepropanoic acid
S-(-)-Carbidopa
S(-)-CARBIDOPA
s1891
SBB000659
SC-12185
SCHEMBL35084
SMP1_000057
SMR000058235
SR-01000597655
SR-01000597655-9
ST055523
Tocris-0455
Tox21_110910
TZFNLOMSOLWIDK-JTQLQIEISA-N
UNII-555UP07D5N component TZFNLOMSOLWIDK-JTQLQIEISA-N
UNII-KR87B45RGH
ZINC19168887

US Patents and Regulatory Information for LODOSYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LODOSYN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Deloitte
Chinese Patent Office
Cantor Fitzgerald
Julphar
Medtronic
US Department of Justice
Colorcon
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.